Company: SCLXW
Filing Date: 2025-02-14
Form Type: PRE 14A
Source: 0001193125-25-027244
Chunk: 38

Company: Scilex Holding Co
Filing Date: 2025-02-14
Form: PRE 14A
Chunk 38
---
6.80 | % |
| 5% Beneficial Owners                                            |     |              |            |     |     |        |       |   |     |                          |            |     |           |        |   |     |       |       |   |
| SCLX Stock Acquisition JV LLC                                   |     |              | 51,529,831 |  -9 |     |        | 21.14 | % |     |                          | 29,057,097 |     |           | 100.00 | % |     |       | 30.44 | % |
| Oramed Pharmaceuticals Inc.                                     |     |              | 15,500,000 | -10 |     |        |  6.20 | % |     |                          |            |     |           |        |   |     |       |  5.49 | % |

| * | Less than 1%. |

| (1) | Unless otherwise indicated, the business address of each of the following individuals is 960 San Antonio 
 Road, Palo Alto, CA 94303.                                                                               |

24

| (2) | Represents 10,744,999 shares subject to options exercisable within 60 days of January 31, 2025, 139,333                                 
 shares held directly and an aggregate of 155,882 shares held by family trusts for the benefit of Mr. Shah, his spouse and his children. |

| (3) | Represents 6,977,541 shares subject to options exercisable within 60 days of January 31, 2025, 320,161                                                                                                                              
 shares held directly, an aggregate of 62,819 shares held through an entity owned by Dr. Ji, 5,640 shares held by Dr. Ji’s spouse and an aggregate of 292,264 shares held by family trusts for the benefit of Dr. Ji, his spouse and 
 his children.                                                                                                                                                                                                                       |

| (4) | Represents 360,569 shares subject to options exercisable within 60 days of January 31, 2025 and 22,840 
 shares held directly.                                                                                  |

| (5) | Represents 101,041 shares subject to options exercisable within 60 days of January 31, 2025, 112,500 
 shares held directly and 11 shares held by Dr. Chun’s child.                                         |

| (6) | Represents 195,192 shares subject to options exercisable within 60